{
  "source": "MFN",
  "fetcher_build": "2026-08-03-nasdaq-fallback-calendar-v5",
  "status": "retrieved",
  "resolution": {
    "status": "resolved",
    "company_name": "BioArctic",
    "expected_name": "BioArctic AB",
    "match_score": 100.0,
    "slug": "bioarctic",
    "url": "https://mfn.se/all/a/bioarctic",
    "metadata": {
      "country": "Sverige",
      "list": "Large Cap Stockholm",
      "sector": "Hälsovård",
      "industry": "Bioteknik",
      "website": "https://mb.cision.com/Main/9978/4378244/4205036.pdf"
    },
    "ticker_candidates": [],
    "attempts": [
      {
        "slug": "bioarctic-ab",
        "url": "https://mfn.se/all/a/bioarctic-ab",
        "status": "identity_mismatch",
        "title": "",
        "score": 0.0
      }
    ]
  },
  "releases": [
    {
      "source": "MFN",
      "fetcher_build": "2026-08-03-nasdaq-fallback-calendar-v5",
      "retrieved_at": "2026-08-03T22:43:00Z",
      "company": "BioArctic AB",
      "issuer_match_score": 8.69204152249135,
      "title": "BioArctic: Försäljningen av Leqembi® uppgick till 29,3 miljarder yen under det andra kvartalet 2026",
      "date": "2026-07-29",
      "report_type": "interim-report",
      "fiscal_year": 2026,
      "quarter": "q2",
      "period": "2026-q2",
      "report_key": "2026:q2",
      "release_url": "https://mfn.se/cis/a/bioarctic/bioarctic-forsaljningen-av-leqembi-r-uppgick-till-29-3-miljarder-yen-under-det-andra-kvartalet-2026-5d0c850f",
      "release_html_path": "D:\\Web\\aktieanalys\\data\\bioarctic-ab\\mfn\\reports\\2026-07-29-bioarctic-forsaljningen-av-leqembi-uppgick-t\\release.html",
      "release_text_path": "D:\\Web\\aktieanalys\\data\\bioarctic-ab\\mfn\\reports\\2026-07-29-bioarctic-forsaljningen-av-leqembi-uppgick-t\\release.txt",
      "attachments": [
        {
          "label": "PDF",
          "url": "https://mb.cision.com/Main/9978/4378244/4205036.pdf",
          "final_url": "https://mb.cision.com/Main/9978/4378244/4205036.pdf",
          "filename": "4205036.pdf",
          "local_path": "D:\\Web\\aktieanalys\\data\\bioarctic-ab\\mfn\\reports\\2026-07-29-bioarctic-forsaljningen-av-leqembi-uppgick-t\\4205036.pdf",
          "content_type": "application/pdf",
          "size": 213177,
          "sha256": "f04a5cfe8526c8d6e488d069386c1024382bbbdced78bc14572ffff53f1fcf9a",
          "extraction": {
            "source_path": "D:\\Web\\aktieanalys\\data\\bioarctic-ab\\mfn\\reports\\2026-07-29-bioarctic-forsaljningen-av-leqembi-uppgick-t\\4205036.pdf",
            "filename": "4205036.pdf",
            "extension": ".pdf",
            "size": 213177,
            "sha256": "f04a5cfe8526c8d6e488d069386c1024382bbbdced78bc14572ffff53f1fcf9a",
            "status": "extracted",
            "text_path": "D:\\Web\\aktieanalys\\data\\bioarctic-ab\\mfn\\reports\\2026-07-29-bioarctic-forsaljningen-av-leqembi-uppgick-t\\extracted\\4205036\\4205036.txt",
            "text_chars": 5968,
            "metadata": {
              "page_count": 2,
              "empty_pages": 0,
              "encrypted": false
            },
            "children": [],
            "warnings": [],
            "manifest_path": "D:\\Web\\aktieanalys\\data\\bioarctic-ab\\mfn\\reports\\2026-07-29-bioarctic-forsaljningen-av-leqembi-uppgick-t\\extracted\\4205036\\4205036.extraction.json"
          }
        }
      ],
      "status": "retrieved"
    }
  ],
  "skipped_because_nasdaq": [
    {
      "report_key": "2026:q1",
      "title": "Delårsrapport januari - mars 2026",
      "date": "2026-05-20",
      "url": "https://mfn.se/cis/a/bioarctic/delarsrapport-januari-mars-2026-768220f0"
    },
    {
      "report_key": "2026:q1",
      "title": "BioArctic: Årsomsättningen för Leqembi® översteg 500 miljoner euro - andra försäljningsmilstolpen uppnådd",
      "date": "2026-04-29",
      "url": "https://mfn.se/cis/a/bioarctic/bioarctic-arsomsattningen-for-leqembi-r-oversteg-500-miljoner-euro-andra-forsaljningsmilstolpen-uppnadd-3329975a"
    },
    {
      "report_key": "2025:annual",
      "title": "BioArctic publicerar årsredovisning och hållbarhetsrapport för 2025",
      "date": "2026-04-21",
      "url": "https://mfn.se/cis/a/bioarctic/bioarctic-publicerar-arsredovisning-och-hallbarhetsrapport-for-2025-7245a4c5"
    },
    {
      "report_key": "2025:q1",
      "title": "BioArctic: Interim Report for the period October - December 2025",
      "date": "2026-02-18",
      "url": "https://mfn.se/cis/a/bioarctic/bioarctic-interim-report-for-the-period-october-december-2025-cf91ca84"
    }
  ],
  "metadata": {
    "country": "Sverige",
    "list": "Large Cap Stockholm",
    "sector": "Hälsovård",
    "industry": "Bioteknik",
    "website": "https://mb.cision.com/Main/9978/4378244/4205036.pdf"
  },
  "ticker_candidates": [],
  "company_url": "https://mfn.se/all/a/bioarctic",
  "company_text_path": "D:\\Web\\aktieanalys\\data\\bioarctic-ab\\mfn\\company.txt",
  "company_html_path": "D:\\Web\\aktieanalys\\data\\bioarctic-ab\\mfn\\company.html"
}